Murali Chakinala
Expertise in
16
conditions

Dr. Murali Chakinala

Intensive Care Medicine
Office
4921 Parkview Pl Ste 8B, 
Saint Louis, MO 
Offers Telehealth
Expertise in
16
conditions
Office
4921 Parkview Pl Ste 8B, 
Saint Louis, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Murali Chakinala is an Intensive Care Medicine provider in Saint Louis, Missouri. Dr. Chakinala is highly rated in 16 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Arteriovenous Malformation, Acute Interstitial Pneumonia, and Lung Transplant.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in MO
Hospital Affiliations
Barnes Jewish Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Cox Health
  • EPO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Essence Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Office
4921 Parkview Pl Ste 8B, Saint Louis, MO 63110
Call: 314-454-8917
Other Locations
Washington University
660 S Euclid Ave, Saint Louis, MO 63110
Call: 314-454-8917

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
A Phase 2, Dose-Ranging, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drug: Rodatristat Ethyl
Study Phase: Phase 2
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia (RDCRN# 6203, Protocol Version Date 07Jan10)
Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia (RDCRN# 6203, Protocol Version Date 07Jan10)
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2025
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
Pulmonary Hypertension and Anastrozole Trial (PHANTOM)
Pulmonary Hypertension and Anastrozole Trial (PHANTOM)
Enrollment Status: Completed
Publish Date: May 01, 2024
Intervention Type: Drug
Study Drug: Anastrozole
Study Phase: Phase 2
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: March 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

71 Total Publications

Endothelial Heterogeneity in Pulmonary Hypertension.
Endothelial Heterogeneity in Pulmonary Hypertension.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: November 13, 2025
View All 71 Publications
Similar Doctors
Expertise in
20
conditions
Dr. Adrian Shifren
Pulmonary Medicine
Expertise in
20
conditions
Dr. Adrian Shifren
Pulmonary Medicine

Washington University

5225 Mid America Plz, 
Saint Louis, MO 
 (0.1 miles away)
800-647-2098
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Adrian Shifren is a Pulmonary Medicine provider in Saint Louis, Missouri. Dr. Shifren is highly rated in 20 conditions, according to our data. His top areas of expertise are Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, and Hypersensitivity Pneumonitis. Dr. Shifren is currently accepting new patients.

Expertise in
17
conditions
Dr. Joseph M. Ojile
Pulmonary Medicine
Expertise in
17
conditions
Dr. Joseph M. Ojile
Pulmonary Medicine

Caduceus Corporation Pulmonary And Sleep Medicine

11200 Tesson Ferry Rd, Suite 100, 
St. Louis, MO 
 (3.0 miles away)
314-849-1500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joseph Ojile is a Pulmonary Medicine provider in St. Louis, Missouri. Dr. Ojile is highly rated in 17 conditions, according to our data. His top areas of expertise are Obstructive Sleep Apnea, Excessive Daytime Sleepiness, Central Sleep Apnea, and Emphysema. Dr. Ojile is currently accepting new patients.

Marin H. Kollef
Expertise in
5
conditions
Dr. Marin H. Kollef
Pulmonary Medicine
Expertise in
5
conditions
Dr. Marin H. Kollef
Pulmonary Medicine

Washington University

1 Barnes Jewish Hospital Plz, 
Saint Louis, MO 
 (11.7 miles away)
314-747-3000
Languages Spoken:
English, Greek
See accepted insurances
Accepting New Patients

Marin Kollef is a Pulmonary Medicine provider in Saint Louis, Missouri. Dr. Kollef is highly rated in 5 conditions, according to our data. His top areas of expertise are Pneumonia, Hospital-Acquired Pneumonia, Acute Respiratory Distress Syndrome (ARDS), Gastrostomy, and Liver Embolization. Dr. Kollef is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chakinala's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Chakinala is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Acute Interstitial Pneumonia
    Dr. Chakinala is
    Distinguished
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Arteriovenous Malformation
    Dr. Chakinala is
    Distinguished
    . Learn about Arteriovenous Malformation.
    See more Arteriovenous Malformation experts
  • Idiopathic Pulmonary Fibrosis
    Dr. Chakinala is
    Distinguished
    . Learn about Idiopathic Pulmonary Fibrosis.
    See more Idiopathic Pulmonary Fibrosis experts
  • Pulmonary Veno-Occlusive Disease
    Dr. Chakinala is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Cerebral Hypoxia
    Dr. Chakinala is
    Advanced
    . Learn about Cerebral Hypoxia.
    See more Cerebral Hypoxia experts
  • Chronic Obstructive Pulmonary Disease (COPD)
    Dr. Chakinala is
    Advanced
    . Learn about Chronic Obstructive Pulmonary Disease (COPD).
    See more Chronic Obstructive Pulmonary Disease (COPD) experts
  • Cystic Fibrosis
    Dr. Chakinala is
    Advanced
    . Learn about Cystic Fibrosis.
    See more Cystic Fibrosis experts
  • Hypersensitivity Pneumonitis
    Dr. Chakinala is
    Advanced
    . Learn about Hypersensitivity Pneumonitis.
    See more Hypersensitivity Pneumonitis experts
  • Interstitial Lung Disease
    Dr. Chakinala is
    Advanced
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
  • Lung Metastases
    Dr. Chakinala is
    Advanced
    . Learn about Lung Metastases.
    See more Lung Metastases experts
View All 11 Advanced Conditions
  • Experienced
  • Acute Respiratory Distress Syndrome (ARDS)
    Dr. Chakinala is
    Experienced
    . Learn about Acute Respiratory Distress Syndrome (ARDS).
    See more Acute Respiratory Distress Syndrome (ARDS) experts
  • Asthma
    Dr. Chakinala is
    Experienced
    . Learn about Asthma.
    See more Asthma experts
  • Asthma in Children
    Dr. Chakinala is
    Experienced
    . Learn about Asthma in Children.
    See more Asthma in Children experts
  • Bronchiectasis
    Dr. Chakinala is
    Experienced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Bronchogenic Cyst
    Dr. Chakinala is
    Experienced
    . Learn about Bronchogenic Cyst.
    See more Bronchogenic Cyst experts
  • Bullae
    Dr. Chakinala is
    Experienced
    . Learn about Bullae.
    See more Bullae experts
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
  1. Homepage
  2. Dr. Murali Chakinala
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.